These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 16368284
21. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes. Testa L, Zoccai GB, Porto I, Trotta G, Agostoni P, Andreotti F, Crea F. Am J Cardiol; 2007 Jun 15; 99(12):1637-42. PubMed ID: 17560866 [Abstract] [Full Text] [Related]
22. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry. Rubboli A, Bolognese L, Di Pasquale G, Galvani M, La Vecchia L, Maggioni AP. J Cardiovasc Med (Hagerstown); 2009 Feb 15; 10(2):200-3. PubMed ID: 19377385 [Abstract] [Full Text] [Related]
23. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Pharmacotherapy; 2007 May 15; 27(5):691-6. PubMed ID: 17461704 [Abstract] [Full Text] [Related]
24. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. James S, Akerblom A, Cannon CP, Emanuelsson H, Husted S, Katus H, Skene A, Steg PG, Storey RF, Harrington R, Becker R, Wallentin L. Am Heart J; 2009 Apr 15; 157(4):599-605. PubMed ID: 19332184 [Abstract] [Full Text] [Related]
29. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? Hermosillo AJ, Spinler SA. Ann Pharmacother; 2008 Jun 15; 42(6):790-805. PubMed ID: 18477734 [Abstract] [Full Text] [Related]
32. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Stenestrand U, Lindbäck J, Wallentin L, RIKS-HIA Registry. Circulation; 2005 Nov 22; 112(21):3225-31. PubMed ID: 16301355 [Abstract] [Full Text] [Related]
37. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis. Lièvre M, Cucherat M. Fundam Clin Pharmacol; 2010 Jun 22; 24(3):385-91. PubMed ID: 19678849 [Abstract] [Full Text] [Related]
38. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, GRACE Investigators. Eur Heart J; 2007 Jul 22; 28(14):1717-22. PubMed ID: 17562671 [Abstract] [Full Text] [Related]
40. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Arch Intern Med; 2007 Feb 12; 167(3):239-45. PubMed ID: 17296878 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]